WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Cytokinetics To Participate In The 22nd Annual Needham Virtual ...
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … WebCytokinetics, South San Francisco, California. 539 likes · 7 talking about this · 100 were here. We are developing potential medicines to improve … phindile sithole
Cytokinetics To Participate In The 22nd Annual Needham Virtual ...
WebContact Us. Main Telephone: (650) 624-3000. Investor Relations – [email protected]. Human Resources – [email protected]. Public Relations … WebOct 8, 2024 · Cytokinetics, which hasn't commercialized a drug while burning through $945 million in its 23 years, had hoped to ask the Food and Drug Administration early next year to approve the drug. The... WebJul 13, 2024 · SOUTH SAN FRANCISCO, Calif., July 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is participating in … phindol